These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Intraocular pressure-raising potential of 1.0% rimexolone in patients responding to corticosteroids. Leibowitz HM; Bartlett JD; Rich R; McQuirter H; Stewart R; Assil K Arch Ophthalmol; 1996 Aug; 114(8):933-7. PubMed ID: 8694727 [TBL] [Abstract][Full Text] [Related]
28. [Efficacy of prednisolone and rimexolone in HLA-B27 positive patients with acute anterior uveitis]. Arellanes-García L; Padilla-Aguilar G; Navarro-López P; Espinoza-Martínez C Gac Med Mex; 2005; 141(5):363-6. PubMed ID: 16353881 [TBL] [Abstract][Full Text] [Related]
29. A comparison of the relative efficacy and clinical performance of olopatadine hydrochloride 0.1% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the conjunctival antigen challenge model. Berdy GJ; Spangler DL; Bensch G; Berdy SS; Brusatti RC Clin Ther; 2000 Jul; 22(7):826-33. PubMed ID: 10945509 [TBL] [Abstract][Full Text] [Related]
30. Bromfenac ophthalmic solution 0.09% (Xibrom) for postoperative ocular pain and inflammation. Donnenfeld ED; Holland EJ; Stewart RH; Gow JA; Grillone LR; Ophthalmology; 2007 Sep; 114(9):1653-62. PubMed ID: 17445902 [TBL] [Abstract][Full Text] [Related]
31. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation. Galor A; Perez VL; Hammel JP; Lowder CY Ophthalmology; 2006 Dec; 113(12):2317-23. PubMed ID: 16996615 [TBL] [Abstract][Full Text] [Related]
32. Development of fluorometholone-loaded PLGA nanoparticles for treatment of inflammatory disorders of anterior and posterior segments of the eye. Gonzalez-Pizarro R; Silva-Abreu M; Calpena AC; Egea MA; Espina M; García ML Int J Pharm; 2018 Aug; 547(1-2):338-346. PubMed ID: 29800741 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of nedocromil 2% versus fluorometholone 0.1%: a randomised, double masked trial comparing the effects on severe vernal keratoconjunctivitis. Tabbara KF; al-Kharashi SA Br J Ophthalmol; 1999 Feb; 83(2):180-4. PubMed ID: 10396195 [TBL] [Abstract][Full Text] [Related]
35. Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease. Robinson MR; Lee SS; Rubin BI; Wayne AS; Pavletic SZ; Bishop MR; Childs R; Barrett AJ; Csaky KG Bone Marrow Transplant; 2004 May; 33(10):1031-5. PubMed ID: 15048138 [TBL] [Abstract][Full Text] [Related]
36. A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells. el-Harazi SM; Ruiz RS; Feldman RM; Villanueva G; Chuang AZ Ophthalmic Surg Lasers; 1998 Jul; 29(7):539-44. PubMed ID: 9674003 [TBL] [Abstract][Full Text] [Related]
37. In vivo efficacy study of the anti-inflammatory properties of Surolan. Bolinder A; Cameron K; Faubert L; Wilson J; Aramini J; Hare J Can J Vet Res; 2006 Jul; 70(3):234-6. PubMed ID: 16850948 [TBL] [Abstract][Full Text] [Related]
38. [The application of corticosteroid following photorefractive keratectomy]. Li W; Wang H; Jiang X Zhonghua Yan Ke Za Zhi; 1997 Jan; 33(1):16-8. PubMed ID: 10436992 [TBL] [Abstract][Full Text] [Related]
39. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study]. Trinquand C; Romanet JP; Nordmann JP; Allaire C; J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585 [TBL] [Abstract][Full Text] [Related]
40. Role of tromaril--a new anti-inflammatory drug in eye diseases. Mehra KS; Agrawal N Ann Ophthalmol; 1984 Feb; 16(2):132-3. PubMed ID: 6367599 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]